PACB vs INMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PACB

43.3
AI Score
VS
INMD Wins

INMD

49.8
AI Score

Investment Advisor Scores

PACB

43score
Recommendation
HOLD

INMD

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PACB INMD Winner
Revenue 78.63M 370.50M INMD
Net Income -102.56M 93.83M INMD
Gross Margin 31.9% 78.5% INMD
Net Margin -130.4% 25.3% INMD
Operating Income -100.99M 85.39M INMD
ROE -89.9% 13.7% INMD
ROA -60.2% 12.2% INMD
Total Assets 170.28M 766.43M INMD
Cash 18.84M 302.54M INMD
Current Ratio 4.90 9.88 INMD
Free Cash Flow -68.28M 84.28M INMD

Relative Price Performance (Last 90 Days)

PACB 1M: +92.4% · 3M: +53.0% INMD 1M: -5.8% · 3M: -3.5%

Current Technical Phase

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 86

RSI (14): 86.4 · Price: $2.54

INMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.3%), weak momentum, RSI 31

RSI (14): 30.7 · Price: $14.09

Fundamentals Snapshot

Metric PACB INMD
Market Cap — —
Forward P/E -6.3 10.3
Trailing P/E — 11.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin -1.1% 0.1%
EPS -0.44 1.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INMD is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.